Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Cisplatin°ú Etoposide ÁÖ»ç¿ë¾×ÀÇ ¾ÈÁ¤¼º¿¡ °üÇÑ ¿¬±¸ Stability of Cisplatin and Etoposide in Normal Solution

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 4È£ p.700 ~ 705
¼Ò¼Ó »ó¼¼Á¤º¸
¿À»óö/Sang Cheul Oh ±è¿µ¹Ì/À¯¿µÀÎ/Á¶¼ÛÀÚ/±èº´¼ö/½Å»ó¿ø/±è¿­È«/±èÁؼ®/Young Mi Kim/Young Inn You/Song Ja Jo/Byung Soo Kim/Sang Won Shin/Yeul Hong Kim/Jun Suk Kim

Abstract

¼­·Ð
1969³â RosenbergµîÀÌ ¹é±ÝÈ­ÇÕ¹°ÀÇ Ç×Á¾¾ç Á¦Àç·Î¼­ÀÇ °¡´É¼ºÀ» º¸°íÇÑ ÀÌ·¡·Î
cisplatinÀº ´Ù¾çÇÑ Á¾¾çµé¿¡ ´ëÇؼ­ ´Üµ¶ ȤÀº º´ÇÕ¿ä¹ý µîÀ¸·Î »ç¿ëµÇ¾î ¿ÔÀ¸¸ç, ƯÈ÷ ´Ù¸¥
¾àÁ¦¿ÍÀÇ º´ÇÕ¿ä¹ýÀº ¼Ò¼¼Æ÷ Æó¾Ï, ³­¼Ò¾ÏÀ̳ª À¯¹æ¾Ï µî¿¡ È¿°ú°¡ ÀÎÁ¤µÇ°í ÀÖ´Ù. ±×·¯³ª
½Åµ¶¼ºÀ̳ª À̵¶¼º, °ñ¼ö¾ïÁ¦, ¿À½É, ±¸Åä µîÀÇ ´Ù¾çÇÑ µ¶¼ºµé·Î ÀÎÇÏ¿© cisplatinÀÇ »ç¿ëÀÌ
Á¦¾àµÇ´Âµ¥ ÀÌ·± ºÎÀÛ¿ë¿¡´Â cisplatinÀÇ ºÐÇع°ÁúÀÌ °ü°èµÈ´Ù´Â º¸°í°¡ ÀÖ´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ
¾àÁ¦ÀÇ º¸°ü ÈÄ Åõ¾à ½Ã ¾àÁ¦ÀÇ ¾ÈÁ¤¼º¿¡ ´ëÇÑ °ËÁõÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú´Ù. Ç×¾ÏÁ¦ Åõ¿© ½Ã ¾Ç
¼º¼¼Æ÷³»·ÎÀÇ ¾àÁ¦ÀÇ À̵¿Á¤µµ´Â ¼¼Æ÷¿Ü °ø°£¿¡¼­ÀÇ ³óµµ¿Í Á¾¾çÀÇ ¾àÁ¦¿¡ ³ëÃâµÈ ½Ã°£¿¡
ºñ·ÊÇÏ¿© Áõ°¡ÇÑ´Ù´Â Á¡°ú ÀÏÁ¤ÇÑ ³óµµ¸¦ ¼­¼­È÷ ÁÖÀÔÇÔÀ¸·Î Çؼ­ ¾àÁ¦ÀÇ ÃÖ°í ³óµµ¿Í °ü°è
ÀÖ´Â ºÎÀÛ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ´Ù´Â ÀåÁ¡À¸·Î ÀÎÇÏ¿© °æÁ¤¸Æ ÁÖ»ç¹æ¹ýÀÌ ¸¹ÀÌ ÀÌ¿ëµÇ°í ÀÖ´Ù. ±×
·¯³ª È¥ÇÕÇÏ´Â cisplatinÀº ÁÖÀÔÇÏ´Â ¾àÁ¦ÀÇ ³óµµ, ¼ö¾×ÀÇ »ê¿°±âµµ ¹× ¼ö¾×¿¡ Æ÷ÇÔµÈ
chlorideÀÇ ³óµµ µîÀÇ ¿ÜºÎ¿äÀÎÀÇ º¯È­¿¡ ¹Î°¨Çϸç, ƯÈ÷ ºû Â÷±¤¿©ºÎ°¡ cisplatinÀÇ ¾ÈÁ¤¼º
¿¡ ¸¹Àº ¿µÇâÀ» ÁØ´Ù°í ¾Ë·ÁÁ® ÀÖÀ¸³ª ÀÌÀÇ ±¤È­ÇÐÀû ÀÛ¿ëÀº ¾ÆÁ÷±îÁö ÀÚ¼¼È÷ ¿¬±¸µÇ¾î ÀÖ
Áö ¾Ê´Ù. Etoposide´Â ¿ëÇصµ°¡ ¸Å¿ì ³·¾Æ ³óµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ħÀü¹°ÀÌ Çü¼ºµÇ´Â Á¦Àç·Î
º¸°íµÇ°í ÀÖ´Ù. º» ÀúÀÚ µîÀº Ç×¾ÏÁ¦ÀÇ È¥ÇÕ¿ë·®°ú ¾ÈÁ¤ÇÑ º¸°ü½Ã°£À» ¾Ë±â À§ÇØ ¼ö¾×È¥ÇÕ
ÈÄ cisplatinÀº º¸°ü ½Ã ¹®Á¦°¡ µÇ´Â Â÷±¤¿©ºÎ ¹× º¸°ü ¿ë±âÀçÁú¿¡ µû¸¥ ¾ÈÁ¤¼ºÀ» °üÂûÇÏ¿´
À¸¸ç etoposide´Â ³óµµ¿¡ µû¸¥ ħÀü¹° Çü¼º¿©ºÎ¸¦ 24½Ã°£µ¿¾È °üÂûÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose: The cisplatin and etoposide had been reported to be an effective anti-tumor
drug for small cell lung cancer, ovarian cancer, breast cancer and so on. The aim of
this study was to evaluate the stability of cisplatin and etoposide in aqueous solution.
Materials and Methods: Cisplatin 200 ¥ìg/ml was prepared in 0.9% sodium chloride
and stored in either glass bottle or polyvinyl chloride(pvc) bag and protected from light
or exposed to fluorescent light. Etoposide solution was prepared in 0.9% sodium chloride,
and contained in glass bottle. Precipitating concentration was achieved using 200 ¥ìg/ml,
400¥ìg/ml, 600 ¥ìg/ml, and 1000 ¥ìg/ml of etoposide solution. Samples were stored at
room temperature and visually inspected and assayed for etoposide and cisplatin content
by high-performance liquid chromatography after 15 minutes, 2, 4, 8, 12, 16 and 24
hours of storage.
Result: 1) Cisplatin concentration decreased less than 10% from initial concentration
for 24 hours of storage, both in glass bottle and pvc bag. Stability of cisplatin 200 ¥ì
g/ml in both container were not different and Condition of light exposure did not have
significant effect on stability of cisplatin 200 ¥ìg/ml in glass bottle. 2) The etoposide
200 ¥ìg/ml was not precipitated and stable for 24 hours, but we could find the
precipitates of etoposide with the concentration of 400 ¥ìg/ml or higher for 24 hours.
Conclusion: Cisplatin 200 ¥ìg/ml and etoposide 200 ¥ìg/ml in 0.9% sodium chloride
were stable at room temperature under room fluorescent light for 24 hours.

Å°¿öµå

Cisplatin; Etoposide; Stability; Acqueous solution.;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS